Altamira Therapeutics cash flow statement data for the quarter ended Dec 2023. This cash flow statement covers 1 quarter of results, standardized by Business Quant from the company’s SEC filings.
| Cash Flow StatementCash Flow | Dec2023 |
|---|---|
| Financing Activities | |
| Change in Capital Stock | |
| Common Stock IssuedStock Issued | 0.11M |
| Net Shares Issued and RepurchasedNet Shares Issued | 0.11M |
| Net Equity Issued and RepurchasedNet Equity Issued | 0.11M |
Pull Altamira Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CYTOF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CYTOF", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CYTOF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();